UnitedHealth Group (NYSE:UNH) Stock Price Expected to Rise, Barclays Analyst Says

UnitedHealth Group (NYSE:UNH) had its target price lifted by investment analysts at Barclays from $386.00 to $391.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the healthcare conglomerate’s stock. Barclays‘s target price indicates a potential upside of 15.38% from the stock’s previous close.

Other research analysts have also issued reports about the stock. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a report on Tuesday, October 28th. Royal Bank Of Canada lifted their price target on UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. KeyCorp raised their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. TD Cowen boosted their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. Finally, Wells Fargo & Company boosted their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Seventeen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $385.75.

UnitedHealth Group Price Performance

UNH stock opened at $338.89 on Monday. The firm has a market cap of $306.98 billion, a P/E ratio of 17.63, a price-to-earnings-growth ratio of 2.03 and a beta of 0.42. UnitedHealth Group has a 1 year low of $234.60 and a 1 year high of $606.36. The stock has a 50-day simple moving average of $330.58 and a 200-day simple moving average of $319.88. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the previous year, the company posted $7.15 earnings per share. The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Norges Bank acquired a new stake in UnitedHealth Group in the 2nd quarter worth about $3,837,207,000. Capital Research Global Investors boosted its holdings in shares of UnitedHealth Group by 126.9% during the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock worth $4,503,419,000 after buying an additional 7,293,009 shares in the last quarter. Berkshire Hathaway Inc acquired a new stake in UnitedHealth Group in the 2nd quarter valued at $1,572,193,000. Dodge & Cox raised its position in UnitedHealth Group by 117.7% in the 2nd quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock valued at $2,729,912,000 after buying an additional 4,730,192 shares during the last quarter. Finally, Capital World Investors increased its position in shares of UnitedHealth Group by 18.8% during the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock valued at $7,516,107,000 after acquiring an additional 3,439,182 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.